^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GAIA-102

    i
    Other names: GAIA-102, peripheral blood mononuclear cells
    Associations

    News

    Trials
    Company:
    GAIA BioMedicine
    Drug class:
    NK cell stimulant
    Related drugs:
    Associations

    News

    Trials
    9ms
    Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors (clinicaltrials.gov)
    P1, N=56, Recruiting, Kyushu University | N=36 --> 56
    Enrollment change
    |
    Opdivo (nivolumab) • GAIA-102
    over2years
    GAIA-102-PD: GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites (clinicaltrials.gov)
    P1/2, N=96, Recruiting, Kyushu University
    New P1/2 trial
    |
    CXCL10 (Chemokine (C-X-C motif) ligand 10) • CXCL9 (Chemokine (C-X-C motif) ligand 9) • CCL20 (C-C Motif Chemokine Ligand 20) • CXCL11 (C-X-C Motif Chemokine Ligand 11)
    |
    Keytruda (pembrolizumab) • GAIA-102